DIMENSIONAL FUND ADVISORS LP - PROTEOSTASIS THERAPEUTICS IN ownership

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$20,000
-20.0%
18,0000.0%0.00%
Q2 2020$25,000
-70.2%
18,000
-75.7%
0.00%
Q1 2020$84,000
+104.9%
73,968
+310.9%
0.00%
Q4 2019$41,000
+57.7%
18,000
-31.7%
0.00%
Q2 2019$26,000
-21.2%
26,3630.0%0.00%
Q1 2019$33,000
-61.2%
26,3630.0%0.00%
Q4 2018$85,000
-4.5%
26,363
-28.8%
0.00%
Q3 2018$89,000
-13.6%
37,0270.0%0.00%
Q2 2018$103,000
-41.5%
37,0270.0%0.00%
Q1 2018$176,000
-37.8%
37,027
-23.7%
0.00%
Q4 2017$283,000
+177.5%
48,5310.0%0.00%
Q3 2017$102,000
-65.5%
48,531
-23.2%
0.00%
Q2 2017$296,00063,1530.00%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,350,000$36,636,0004.04%
EcoR1 Capital, LLC 602,315$9,390,0002.88%
NEA Management Company, LLC 3,556,778$55,450,0002.49%
Opaleye Management Inc. 152,000$2,370,0001.24%
Avoro Capital Advisors LLC 179,565$2,799,0000.49%
Monashee Investment Management LLC 85,000$1,325,0000.47%
Rock Springs Capital Management LP 450,000$7,016,0000.44%
Perceptive Advisors 344,550$5,372,0000.35%
Hillhouse Capital Management 763,790$11,907,0000.24%
Eventide Asset Management 220,000$3,430,0000.21%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders